1-20 of 67
Anna Azvolinsky, PhD
Close
Sort by
News

Oral Drug Effective for Rare WHIM Syndrome, Approved by FDA

Anna Azvolinsky, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Oral Drug Effective for Rare WHIM Syndrome, Approved by FDA
News

Mosunetuzumab Therapy Elicits High, Durable Responses in Patients With Follicular Lymphoma

Anna Azvolinsky, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Mosunetuzumab Therapy Elicits High, Durable Responses in Patients With Follicular Lymphoma
News

Safety of Oral Azacytidine in Patients With Lower-Risk MDS Consistent With Prior Results

Anna Azvolinsky, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Safety of Oral Azacytidine in Patients With Lower-Risk MDS Consistent With Prior Results
News

Addition of Avatrombopag to Cyclosporine Can Improve Response Rate in Elderly Patients with Transfusion-Dependent, Non-Severe Aplastic Anemia

Anna Azvolinsky, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Addition of Avatrombopag to Cyclosporine Can Improve Response Rate in Elderly Patients with Transfusion-Dependent, Non-Severe Aplastic Anemia
News

Teclistamab Combination with Daratumumab, Lenalidomide Shows Promising Efficacy, Tolerability in Patients with NDMM

Anna Azvolinsky, PhD
Published: 2024
Abstract
Mid-July 2024
View News titled, Teclistamab Combination with Daratumumab, Lenalidomide Shows Promising Efficacy, Tolerability in Patients with NDMM
News

Short-Lived Responses to Anti-BCMA CAR T-Cell Therapy in Patients With MM Associated With Increased Cytotoxic CD4+ CAR T Cells

Anna Azvolinsky, PhD
Published: 2024
Abstract
July 2024
View News titled, Short-Lived Responses to Anti-BCMA CAR T-Cell Therapy in Patients With MM Associated With Increased Cytotoxic CD4+ CAR T Cells
News

CDC Guideline Results in Drop in Opioid Prescriptions for Patients with Sickle Cell Disease

Anna Azvolinsky, PhD
Published: 2024
Abstract
June 2024
View News titled, CDC Guideline Results in Drop in Opioid Prescriptions for Patients with Sickle Cell Disease
News

Researchers Developing a Blueprint for BCMA-Targeted T-Cell Therapy for Multiple Myeloma

Anna Azvolinsky, PhD
Published: 2024
Abstract
June 2024
View News titled, Researchers Developing a Blueprint for BCMA-Targeted T-Cell Therapy for Multiple Myeloma
News

Obesity Associated with Precursor to MM

Anna Azvolinsky, PhD
Published: 2024
Abstract
April 2024
View News titled, Obesity Associated with Precursor to MM
News

Statin Use Linked to Reduced Heart Failure, Risk of Death Among Patients with Non-Hodgkin Lymphoma

Anna Azvolinsky, PhD
Published: 2024
Abstract
April 2024
View News titled, Statin Use Linked to Reduced Heart Failure, Risk of Death Among Patients with Non-Hodgkin Lymphoma
News

Detection of Persistent Free Light Chain Using Mass Spectrometry Is a Sensitive Marker of OS in AL Amyloidosis

Anna Azvolinsky, PhD
Published: 2024
Abstract
March 2024
View News titled, Detection of Persistent Free Light Chain Using Mass Spectrometry Is a Sensitive Marker of OS in AL Amyloidosis
News

Global Real-World Patient Survey Identifies Need for Support, Patient Education in CLL

Anna Azvolinsky, PhD
Published: 2023
Abstract
January Supplement 2024
View News titled, Global Real-World Patient Survey Identifies Need for Support, Patient Education in CLL
News

Review Analyzes Cardiovascular Toxicities Associated With Bruton Tyrosine Kinase Inhibitors in CLL

Anna Azvolinsky, PhD
Published: 2023
Abstract
January Supplement 2024
View News titled, Review Analyzes Cardiovascular Toxicities Associated With Bruton Tyrosine Kinase Inhibitors in CLL
News

Triple-Combination Regimen of Quizartinib, Venetoclax, and Decitabine Effective in Patients with FLT3-ITD Mutated AML

Anna Azvolinsky, PhD
Published: 2023
Abstract
January 2024
View News titled, Triple-Combination Regimen of Quizartinib, Venetoclax, and Decitabine Effective in Patients with FLT3-ITD Mutated AML
News

Reduced Dose Intensity of Talquetamab May Help Improve Long-Term GPRC5D-Associated Toxicities in Patients With Multiple Myeloma

Anna Azvolinsky, PhD
Published: 2023
Abstract
January 2024
View News titled, Reduced Dose Intensity of Talquetamab May Help Improve Long-Term GPRC5D-Associated Toxicities in Patients With Multiple Myeloma
News

New Complement-Targeted Therapy Improves Quality-of-Life Measures for Patients With Paroxysmal Nocturnal Hemoglobinuria

Anna Azvolinsky, PhD
Published: 2023
Abstract
January 2024
View News titled, New Complement-Targeted Therapy Improves Quality-of-Life Measures for Patients With Paroxysmal Nocturnal Hemoglobinuria
News

Venetoclax Combo Delays Transformation to AML But Does Not Improve Survival in Patients with CMML

Anna Azvolinsky, PhD
Published: 2023
Abstract
January 2024
View News titled, Venetoclax Combo Delays Transformation to AML But Does Not Improve Survival in Patients with CMML
News

MRD-Directed Combo of Ibrutinib Plus Venetoclax Improves PFS, OS Among Patients With Treatment-Naïve CLL

Anna Azvolinsky, PhD
Published: 2023
Abstract
January 2024
View News titled, MRD-Directed Combo of Ibrutinib Plus Venetoclax Improves PFS, OS Among Patients With Treatment-Naïve CLL
News

Race, Ethnicity Do Not Impact PFS, OS Among Patients with MM Treated with BCMA CAR-T Cells

Anna Azvolinsky, PhD
Published: 2023
Abstract
December 2023
View News titled, Race, Ethnicity Do Not Impact PFS, OS Among Patients with MM Treated with BCMA CAR-T Cells
News

Biomarkers Related to VTE Risk Decrease Within Weeks of Stopping Combined Hormonal Contraception

Anna Azvolinsky, PhD
Published: 2023
Abstract
December 2023
View News titled, Biomarkers Related to VTE Risk Decrease Within Weeks of Stopping Combined Hormonal Contraception